Lorenzen, S., Biederstädt, A., Ronellenfitsch, U., Reißfelder, C., Mönig, S. P., Wenz, F., . . . Hofheinz, R. (2020). RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction: A randomized phase III joint study of the AIO, ARO and DGAV. BMC cancer, 20, . https://doi.org/10.1186/s12885-020-07388-x
Chicago-Zitierstil (17. Ausg.)Lorenzen, Sylvie, et al. "RACE-trial: Neoadjuvant Radiochemotherapy Versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction: A Randomized Phase III Joint Study of the AIO, ARO and DGAV." BMC Cancer 20 (2020). https://doi.org/10.1186/s12885-020-07388-x.
MLA-Zitierstil (9. Ausg.)Lorenzen, Sylvie, et al. "RACE-trial: Neoadjuvant Radiochemotherapy Versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction: A Randomized Phase III Joint Study of the AIO, ARO and DGAV." BMC Cancer, vol. 20, 2020, https://doi.org/10.1186/s12885-020-07388-x.